Briefly: More colorectal cancer patients experience severe rash from Erbitux than other cancer patients, and significantly more men and younger people have severe rash than women and patients over 70.

Where you live in the United States makes a big difference in your risk of being uninsured from more than 40 percent of people living in Houston to a little more than 3 percent of those in Worchester, MA.

A new method of testing cancer drugs directly on fresh tumor tissue may speed drug development by reducing the need for the earliest human testing. Read the rest of this entry »